SELECTIS HEALTH INC | 10-Q: Quarterly report
Selectis Health Appoints Jim Creamer as Interim Finance Chief
Selectis Health to Sell Four Skilled Nursing Facilities in Georgia for $31M
Selectis Health to Present at the Rocky Mountain Microcap Conference X
Greenwood Village, CO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company"), is scheduled to present at Trickle Research's Rocky Mountain Microcap Confer
Selectis Health Appoints Andrew Sink to Board of Directors
- Company Concurrently Announces Resignation of Clifford Neuman as Director and Secretary - - Sink's Appointment as Independent Director Fulfills Remaining Corporate Governance Requirements for Major
Selectis Health to Present at the LD Micro Main Event XV
Greenwood Village, CO, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company"), is scheduled to present at the 15th Annual LD Micro Main Event, which is bei
Earnings Flash (GBCS) SELECTIS HEALTH Reports Q2 Revenue $11.5M
08:31 AM EDT, 09/19/2022 (MT Newswires) --
Selectis Health Provides Business Update
- First Quarter 2022 Revenue Increased Over 75% Year-over-Year - - Sustained Census and Operational Improvements Drive Strategic Progress Through the First Half of 2022 - - Christine Lucus Appointed a
Selectis Health Postpones Fourth Quarter and Full Year 2021 Conference Call, Originally Scheduled for April 26, 2022 at 4:30 p.m. Eastern Time
Greenwood Village, CO, April 26, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") announced that it will be postponing its scheduled conference call on Tuesda
Selectis Health to Hold Fourth Quarter and Full Year 2021 Conference Call on Tuesday, April 26, 2022 at 4:30 p.m. ET
Greenwood Village, CO, April 20, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") will hold a conference call on Tuesday, April 26, 2022 at 4:30 p.m. ET to di
Selectis Health Partners with Gateway Group to Lead Expanded Investor Relations Program
Greenwood Village, CO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC:GBCS) ("Selectis" or the "Company") announced that it has engaged Gateway Group, Inc., a leading strategic financial communications and capital markets advisory firm, t
Selectis Health Reports Third Quarter 2021 Financial Results
Greenwood Village, Colorado, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") today reported a Net Loss for the three months ended September 30, 2021
Selectis Health Schedules Third Quarter Earnings Call for Tuesday, November 16, 2021
Greenwood Village, Colorado, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company"), announced today that it expects to issue its third quarter 2021 financ
Global Flexible Packaging Market (2021 to 2029) - Featuring Amcor, Bemis and Universal Plastic Among Others
DUBLIN, Sept. 6, 2021 /PRNewswire/ -- The "Flexible Packaging Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 202
Healthcare Analytics Market to Reach $96.90 Bn, Globally, by 2030 at 15.3% CAGR: Allied Market Research
PORTLAND, Ore., Sept. 6, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Healthcare Analytics Market by Application (Financial Analysis, Operational & Administrative Ana
Worldwide Machine Learning Industry to 2029 - Increasing Demand for Intelligent Business Processes Presents Opportunities
DUBLIN, Sept. 3, 2021 /PRNewswire/ -- The "Machine Learning Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021
Neurocrine Biosciences to Present at Upcoming Healthcare Conferences
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that members of the management team will participate at the following virtual investor conference
Viking Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic a
American Regent Launches Multrys™ (trace elements injection 4*, USP)
MELVILLE, N.Y., Sept. 2, 2021 /PRNewswire/ -- American Regent, Inc. introduces FDA-approved Multrys™ (trace elements injection 4*, USP). Multrys™ is indicated in neonatal and pediatric patients weig
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mecha
No Data